NEWS
NEWS
REACX PHARMACEUTICALS AWARDED $10.35 MILLION GRANT TO ADVANCE NALMEFENE IMPLANT FOR OPIOID RELAPSE PREVENTION
February 3, 2025
Implant to use the Company’s proprietary ProNeura™ drug delivery system. February 3, 2025 – ReacX Pharmaceuticals, Inc. (“ReacX” or the “Company”), a company focused on developing and marketing pharmaceutical treatments